Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Bronchogenic × alectinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 12 Neoplasms 4 Lung Neoplasms 4 Solid Tumors 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 2a 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Diseases 1 Hematologic Neoplasms 1 Genomic Instability 1 Central Nervous System Neoplasms 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 ALK+ Advanced NSCLC 1

Interventions

Carboplatin 7 pembrolizumab 4 Pemetrexed 4 Paclitaxel 4 Cisplatin 3 selpercatinib 2 pralsetinib 2 durvalumab 2 atezolizumab 2 Radiosurgery 2 Gemcitabine 2 taletrectinib 1 repotrectinib 1 ceralasertib 1 cemiplimab 1 Platinum Compounds 1 Nivolumab 1 Interleukin-15 1 Docetaxel 1 Blood Specimen Collection 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡